Regulating The Products Of Nanotechnology: Does FDA Have The Tools It Needs?
Taylor finds there are gaps in legal authority and fundamental inadequacies in resources that FDA faces as it attempts to better understand and manage the potential risks from hundreds of new products utilizing nanotechnology entering the marketplace in areas such as cosmetics, dietary supplements, food, and drugs. Taylor sets out a necessary course of action for the FDA, Congress, and industry to address these gaps. He also examines whether FDA should classify some nanoscale materials as \"new\" for legal, regulatory, and safety purposes.
More than $32 billion in nanotechnology products were sold globally last year and, by 2014, Lux Research projects $2.6 trillion in manufactured goods will incorporate nanotechnology. Nanotechnology refers to the emerging science of manufacturing materials that are measured in nanometers, usually at the 1-100 nanometers scale. The head of a pin is 1 million nanometers wide.
Release of new report, Regulating the Products of Nanotechnology: Does FDA Have the Tools It Needs?
Michael R. Taylor, former FDA deputy commissioner for policy and author of new report on nanotechnology; David Rejeski, director, Project on Emerging Nanotechnologies.
Thursday, October 5, 12 noon - 1 p.m. (Lunch available at 11:30 a.m.)
Woodrow Wilson International Center for Scholars, 5th Floor Conference Room. Ronald Reagan Building and International Trade Center, 1300 Pennsylvania Avenue, NW The Project on Emerging Nanotechnologies was launched in 2005 by the Woodrow Wilson Center and The Pew Charitable Trusts. It is dedicated to helping businesses, governments, and the public anticipate and manage the possible health and environmental implications of nanotechnology. For more information about the project, log on to: http://www.nanotechproject.org.
Woodrow Wilson International Center for Scholars
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
Backing, Christopher. "Regulating The Products Of Nanotechnology: Does FDA Have The Tools It Needs?." Medical News Today. MediLexicon, Intl., 29 Sep. 2006. Web.
30 Mar. 2017. <http://www.medicalnewstoday.com/releases/53000.php>
Backing, C. (2006, September 29). "Regulating The Products Of Nanotechnology: Does FDA Have The Tools It Needs?." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.